Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors

A new coronavirus strain called as SARS-CoV-2 has emerged from Wuhan, China in late 2019 and it caused a worldwide pandemic in a few months. After the Second World War, it is the biggest calamity observed as there is no specific US Food and Drugs Administration (USFDA) approved drug or vaccine avail...

Descripción completa

Detalles Bibliográficos
Autores principales: Uddin, Reaz, Jalal, Khurshid, Khan, Kanwal, ul-Haq, Zaheer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602124/
https://www.ncbi.nlm.nih.gov/pubmed/34815586
http://dx.doi.org/10.1016/j.molstruc.2021.131920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602124/
https://www.ncbi.nlm.nih.gov/pubmed/34815586
http://dx.doi.org/10.1016/j.molstruc.2021.131920

Ejemplares similares